2.8800
-0.0140
(-0.48%)
As of 8:09:04 AM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHHABRA MEENU Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| FERRANTE KAREN JEAN M.D. Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| HEIDEN WILLIAM K Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| HURWITZ EDWARD Director | Conversion of Exercise of derivative security | May 20, 2024 | 37,574 |
| JACKSON SCOTT THOMAS Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| KOENIG SCOTT Chief Executive Officer | Stock Gift | Oct 7, 2024 | 427,480 |
| LIU MARGARET A Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| O'BRIEN FEDERICA F Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| SIEGEL JAY PHILIP M.D. Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
| STUMP DAVID CARTER Director | Conversion of Exercise of derivative security | May 20, 2024 | 4,500 |
Related Tickers
3G0.BE Altimmune Inc
6.74
+0.42%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
8AW0.BE Ocean Biomedical Inc
0.1910
+5.52%
1VT.DU Viking Therapeutics Inc
32.65
+1.56%
2UV.F Applied Therapeutics, Inc.
0.5470
+6.21%
2UV.DU Applied Therapeutics Inc
0.5720
-0.44%
AT20.F Atara Biotherapeutics, Inc.
8.05
+8.05%
8AW0.F Ocean Biomedical, Inc.
0.1710
-22.27%
0M4.DU Mersana Therapeutics Inc
0.6000
+1.59%
BX2.BE BioXcel Therapeutics Inc
0.3046
-2.09%